Recombinant Human C1 Inhibitor for Treatment of Heredit* - Jan Nuijens

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: Food and Drug Administration (FDA)
Type: Research Project (R01)
Project #: 3R01FD003086-01S1
Application #: 7675911
Study Section: Special Emphasis Panel (ZFD1-OPD-L (C1))
Program Officer: Ganti, Usha

Project Start: 2006-09-20
Project End: 2009-08-31
Budget Start: 2006-09-20
Budget End: 2009-08-31
Support Year: 1
Fiscal Year: 2008
Total Cost
Indirect Cost

Institution

Name: Pharming Technologies, B.V.
Department
Type
DUNS #

City: Leiden
State
Country: Netherlands
Zip Code

Related projects


NIH 2008 R01 FD	Recombinant Human C1 Inhibitor for Treatment of Heredit* Nuijens, Jan H. / Pharming Technologies, B.V.
NIH 2006 R01 FD	Recombinant Human C1 Inhibitor for Treatment of Heredit* Nuijens, Jan H. / Pharming Technologies, B.V.

Comments

Be the first to comment on Jan Nuijens's grant